Global · Regional research hubs
Research Peptides by Region
Peptide science is international; the rules around it are not. These regional guides explain who regulates research materials in each market, where the research is actually done, and which educational guides answer the questions readers there ask most.
Why regional context matters
The same compound can be an authorised medicine in one country, a scheduled substance in another and an unapproved research chemical in a third — with no change to the underlying evidence. Reading peptide research well means holding those two questions apart: what does the literature show, and what status does this substance have where you are.
We publish a regional page only where the regulatory framework, research ecosystem or terminology genuinely differs. Where they do not, one clear international guide serves readers better than a dozen near-duplicates.
Europe
United Kingdom
MHRA · 4 research centres referenced
Spain
AEMPS · 4 research centres referenced
Ireland
HPRA · 4 research centres referenced
Germany
BfArM · 4 research centres referenced
France
ANSM · 4 research centres referenced
Italy
AIFA · 4 research centres referenced
Netherlands
CBG-MEB · 4 research centres referenced
Belgium
FAMHP · 4 research centres referenced
North America
Oceania
Middle East
Asia
Start with the science
Regional context is useful, but the science is the same everywhere. If you are new to the subject, begin with what peptides actually are, then work through the research hubs and the limits of the current evidence.
Frequently asked questions
- What are these regional pages for?
- Each one explains how peptide research is regulated, funded and discussed in a specific market, and points to the educational guides most relevant to readers there. They are not sales pages — Peptide Intel Hub sells nothing.
- Why are there no city pages?
- Because peptide research does not meaningfully differ between two cities in the same country. Publishing near-identical pages for hundreds of cities is a doorway-page pattern, and we deliberately do not do it. A regional page is only published when its regulatory and research context is genuinely different.
- Does regulation change the science?
- No. Regulatory status and scientific evidence are independent. A compound can be well studied and unapproved, or approved for one narrow indication and poorly studied for everything else. Every page here keeps those separate.